机译:MGD007的开发,一种GPA33 x CD3-双特异性蛋白,用于转移结直肠癌的T细胞免疫疗法
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics San Francisco CA USA;
MacroGenics San Francisco CA USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics San Francisco CA USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
MacroGenics Inc 9704 Med Ctr Dr Rockville MD 20850 USA;
机译:MGD007的开发,一种GPA33 x CD3-双特异性蛋白,用于转移结直肠癌的T细胞免疫疗法
机译:来自先前接受过化疗的患者的转移性结直肠癌细胞对CEA | [sol] | CD3双特异性T细胞结合BiTE抗体介导的T细胞杀伤敏感
机译:撤回注释:用维生素D结合蛋白衍生的巨噬细胞激活因子GcMAF免疫治疗转移性结直肠癌[Cancer Immunology,Immunotherapy,57,(2008)1007-1016,DOI 10.1007 / s00262-007-0431-z]
机译:富含富含肝素的脂肪筏中蛋白质的差异分析,转移性结直肠癌克隆
机译:新型结肠直肠癌促进转移性疾病治疗的疗效
机译:MGD007(人源化gpA33×CD3双亲和力重新靶向(DART®)蛋白)在I型患者中进行的首次人为开放标签剂量递增研究用于复发/难治性转移性结直肠癌患者
机译:MGD007的开发,一种用于转移结直肠癌的T细胞免疫疗法的GPA33 X CD3-双特异性蛋白质